| Cellular sources of TSPO expression in healthy and diseased brain E Nutma, K Ceyzériat, S Amor, S Tsartsalis, P Millet, DR Owen, ... European Journal of Nuclear Medicine and Molecular Imaging, 1-18, 2021 | 137 | 2021 |
| Diverse human astrocyte and microglial transcriptional responses to Alzheimer’s pathology AM Smith, K Davey, S Tsartsalis, C Khozoie, N Fancy, SS Tang, E Liaptsi, ... Acta neuropathologica 143 (1), 75-91, 2022 | 135 | 2022 |
| Translocator protein is a marker of activated microglia in rodent models but not human neurodegenerative diseases E Nutma, N Fancy, M Weinert, S Tsartsalis, MC Marzin, RCJ Muirhead, ... Nature Communications 14 (1), 5247, 2023 | 97 | 2023 |
| Vascular endothelial growth factor (VEGF) in the pathogenesis of diabetic nephropathy of type 1 diabetes mellitus M Mironidou-Tzouveleki, S Tsartsalis, C Tomos Current drug targets 12 (1), 107-114, 2011 | 75 | 2011 |
| In vivo TSPO signal and neuroinflammation in Alzheimer’s disease BB Tournier, S Tsartsalis, K Ceyzériat, V Garibotto, P Millet Cells 9 (9), 1941, 2020 | 71 | 2020 |
| Astrocytic TSPO upregulation appears before microglial TSPO in Alzheimer’s disease BB Tournier, S Tsartsalis, K Ceyzériat, BH Fraser, MC Grégoire, E Kövari, ... Journal of Alzheimer's Disease 77 (3), 1043-1056, 2020 | 60 | 2020 |
| TSPO and amyloid deposits in sub-regions of the hippocampus in the 3xTgAD mouse model of Alzheimer’s disease BB Tournier, S Tsartsalis, D Rigaud, C Fossey, T Cailly, F Fabis, T Pham, ... Neurobiology of disease 121, 95-105, 2019 | 54 | 2019 |
| Fluorescence-activated cell sorting to reveal the cell origin of radioligand binding BB Tournier, S Tsartsalis, K Ceyzériat, Z Medina, BH Fraser, MC Grégoire, ... Journal of Cerebral Blood Flow & Metabolism 40 (6), 1242-1255, 2020 | 50 | 2020 |
| Early Alzheimer-type lesions in cognitively normal subjects S Tsartsalis, A Xekardaki, PR Hof, E Kövari, C Bouras Neurobiology of aging 62, 34-44, 2018 | 44 | 2018 |
| Dopaminergic dysfunction in the 3xTg-AD mice model of Alzheimer’s disease Y Gloria, K Ceyzériat, S Tsartsalis, P Millet, BB Tournier Scientific reports 11 (1), 19412, 2021 | 39 | 2021 |
| Alterations in dopamine system and in its connectivity with serotonin in a rat model of Alzheimer’s disease K Ceyzériat, Y Gloria, S Tsartsalis, C Fossey, T Cailly, F Fabis, P Millet, ... Brain Communications 3 (2), fcab029, 2021 | 33 | 2021 |
| Alzheimer’s disease-related transcriptional sex differences in myeloid cells I Coales, S Tsartsalis, N Fancy, M Weinert, D Clode, D Owen, ... Journal of neuroinflammation 19 (1), 247, 2022 | 29 | 2022 |
| A single nuclear transcriptomic characterisation of mechanisms responsible for impaired angiogenesis and blood-brain barrier function in Alzheimer’s disease S Tsartsalis, H Sleven, N Fancy, F Wessely, AM Smith, N Willumsen, ... Nature Communications 15 (1), 2243, 2024 | 27 | 2024 |
| Dopamine D2/3 Receptor Availabilities and Evoked Dopamine Release in Striatum Differentially Predict Impulsivity and Novelty Preference in Roman High- and … L Bellés, A Dimiziani, S Tsartsalis, P Millet, FR Herrmann, N Ginovart International Journal of Neuropsychopharmacology 24 (3), 239-251, 2021 | 20 | 2021 |
| Low dose pioglitazone does not affect bone formation and resorption markers or bone mineral density in streptozocin-induced diabetic rats E Tsirella, T Mavrakanas, O Rager, S Tsartsalis, K Kallaras, B Kokkas, ... Journal of Physiology and Pharmacology 63 (2), 201, 2012 | 18 | 2012 |
| Quantification of GABAA receptors in the rat brain with [123I] iomazenil SPECT from factor analysis-denoised images S Tsartsalis, M Moulin-Sallanon, N Dumas, BB Tournier, C Ghezzi, ... Nuclear medicine and biology 41 (2), 186-195, 2014 | 17 | 2014 |
| Characterisation of premature cell senescence in Alzheimer’s disease using single nuclear transcriptomics NN Fancy, AM Smith, A Caramello, S Tsartsalis, K Davey, RCJ Muirhead, ... Acta Neuropathologica 147 (1), 78, 2024 | 15 | 2024 |
| SPECT imaging of glioma with radioiodinated CLINDE: evidence from a mouse GL26 glioma model S Tsartsalis, N Dumas, BB Tournier, T Pham, M Moulin-Sallanon, ... EJNMMI research 5, 1-6, 2015 | 15 | 2015 |
| Nanotechnology and radiopharmaceuticals: Diagnostic and therapeutic approaches M Mironidou-Tzouveleki, S Tsartsalis Current Drug Delivery 7 (2), 168-174, 2010 | 14 | 2010 |
| Time-dependent effects of repeated THC treatment on dopamine D2/3 receptor-mediated signalling in midbrain and striatum BB Tournier, S Tsartsalis, A Dimiziani, P Millet, N Ginovart Behavioural brain research 311, 322-329, 2016 | 13 | 2016 |
